#generalisedmyastheniagravis #gMG #UCB #Rystiggo #rozanolixizumab #NICE #NHS #HEOR #Neuromusculardiseases #uncontrolledgMGtherapy #rarediseases #NICEguidance #reimbursement #NICEcosteffectivenessmodelling #NICEdecisionmaking #InnovativeMedicinesFund #IMF #gMGcommunitypatients
zurl.co/Tj9mI
zurl.co/Tj9mI
NICE backs UCB drug as first uncontrolled gMG therapy
UCB's Rystiggo can be used by the NHS as a backup treatment for people with the rare autoimmune and neuromuscular disease gMG, says NICE.
pharmaphorum.com
May 6, 2026 at 9:38 AM